PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Mayo Clinic scientists propose a breast cancer drug for bladder cancer patients

2014-01-22
(Press-News.org) Contact information: Sam Smith
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Mayo Clinic scientists propose a breast cancer drug for bladder cancer patients ROCHESTER, Minn. ― Jan. 21, 2014 ― Researchers at Mayo Clinic have found amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC) and have shown that the presence of HER2 amplification is associated with particularly aggressive tumors. These findings suggest that administering trastuzumab to MPUC patients with HER2 amplification could improve outcomes, just as it has for breast cancer. The study is published in this month's Modern Pathology.

As with breast cancer, HER2 amplification in MPUC results in a faster growing form of cancer that spreads quickly and has a higher chance of recurrence. The hope is that combating this amplification with trastuzumab, a drug that is effective in HER2 positive breast cancers, will result in effective therapy against bladder cancer.

"These findings show it is critical for pathologists to recognize this type of bladder cancer and that providers order the appropriate tests," says John Cheville, M.D., a Mayo Clinic pathologist and lead author of the study. "This will be essential for any clinical trial examining the effectiveness of trastuzmab in treating MPUC."

The study identified HER2 amplification in 15 percent of patients with MPUC, compared to 9 percent of typical bladder cancers. Patients with HER2-amplified MPUC were more likely to have aggressive tumors than patients whose tumors did not have HER2 amplification, according to this study.

"Targeted treatments for HER2 positive breast cancer have led to markedly improved survival," says Dr. Cheville. "In one sense, what we are trying to do with HER2 positive bladder cancer is a relatively simple thing. We are trying to identify prognostic and therapeutic biomarkers, and ultimately match the most effective drug to the individual patient's tumor, rather than its location in the body."

HER2 is a very important target in breast cancer therapy, and gene amplification occurs in approximately 20–30 percent of cases, says Dr. Cheville. Using the latest molecular techniques, researchers in the Mayo Clinic Center for Individualized Medicine's Biomarker Discovery Program determined that some bladder cancers similarly show HER2 amplification and produce too much of the HER2 protein product, resulting in more rapid tumor growth and expansion.

This type of individualized therapy represents the future of cancer care, and findings like the one reported in Modern Pathology are only the beginning of many more to come, Dr. Cheville says. Last year, the Biomarker Discovery Program identified and validated 12 different molecular/genomic markers, most of them related to the diagnosis, treatment and prognosis of a variety of cancers.

### About Mayo Clinic Recognizing 150 years of serving humanity in 2014, Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit 150years.mayoclinic.org, http://www.mayoclinic.org and newsnetwork.mayoclinic.org.

About the Mayo Clinic Center for Individualized Medicine The Center for Individualized Medicine discovers and integrates the latest in genomic, molecular and clinical sciences into personalized care for each Mayo Clinic patient. Visit http://mayoresearch.mayo.edu/center-for-individualized-medicine for more information.


ELSE PRESS RELEASES FROM THIS DATE:

X-ray diffraction technique 'maps' strain and crack propagation in metallic tubing

2014-01-22
X-ray diffraction technique 'maps' strain and crack propagation in metallic tubing A team of researchers exploring the intergranular stress corrosion cracking of a type of metallic tubing used within nuclear power plants has developed a technique to both map and ...

3-D imaging provides window into living cells, no dye required

2014-01-22
3-D imaging provides window into living cells, no dye required CHAMPAIGN, Ill. — Living cells are ready for their close-ups, thanks to a new imaging technique that needs no dyes or other chemicals, yet renders high-resolution, three-dimensional, ...

New avenue to treat diabetes-related vision problems

2014-01-22
New avenue to treat diabetes-related vision problems Eye on dopamine Dopamine-restoring drugs already used to treat Parkinson's disease may also be beneficial for the treatment of diabetic retinopathy, a leading cause of blindness in adults, researchers have discovered. The ...

No-till soybean fields give (even some rare) birds a foothold in Illinois

2014-01-22
No-till soybean fields give (even some rare) birds a foothold in Illinois CHAMPAIGN, Ill. — Researchers report in a new study that several bird species – some of them relatively rare – are making extensive use of soybean fields in Illinois. The team ...

Live feed into our bodies

2014-01-22
Live feed into our bodies A palm-top device developed by UCSB researchers provides real-time insight into how fast a living body metabolizes drugs, opening the door to highly personalized medicine (Santa Barbara, Calif.) — A device that ...

Sedentary behavior and low physical activity linked to heart failure in men

2014-01-22
Sedentary behavior and low physical activity linked to heart failure in men PASADENA, CALIF., 21, 2014 — Men who reported being sedentary with low levels of physical activity were at a significantly higher risk for heart failure than those who were more active, ...

Cancer diagnosis doesn't increase a child's risk of post-traumatic stress disorder

2014-01-22
Cancer diagnosis doesn't increase a child's risk of post-traumatic stress disorder A St. Jude Children's Research Hospital study found that despite being diagnosed with life-threatening illnesses, childhood cancer patients are no more likely than ...

Subterranean 'sedimentary bathtub' amplifies earthquakes

2014-01-22
Subterranean 'sedimentary bathtub' amplifies earthquakes A basin of stiff soil beneath Vancouver might make earthquakes there more severe than expected, a San Diego State University seismologist finds SAN DIEGO, Calif. (Jan. 21, 2014)— Like an amphitheater amplifies ...

Emergency treatment takes longer for heart attack victims during off-hours

2014-01-22
Emergency treatment takes longer for heart attack victims during off-hours ROCHESTER, Minn. — Jan. 21, 2014 — More people die and emergency hospital treatment takes longer for heart attack victims who arrive at the hospital during off-hours (nights and weekends), compared ...

White, green or black roofs? Berkeley Lab report compares economic payoffs

2014-01-22
White, green or black roofs? Berkeley Lab report compares economic payoffs Looking strictly at the economic costs and benefits of three different roof types—black, white and "green" (or vegetated)—Lawrence Berkeley National Laboratory (Berkeley Lab) ...

LAST 30 PRESS RELEASES:

New strategies to enhance chiral optical signals unveiled

Cambridge research uncovers powerful virtual reality treatment for speech anxiety

2025 Gut Microbiota for Health World Summit to spotlight groundbreaking research

International survey finds that support for climate interventions is tied to being hopeful and worried about climate change

Cambridge scientist launches free VR platform that eliminates the fear of public speaking

Open-Source AI matches top proprietary model in solving tough medical cases

Good fences make good neighbors (with carnivores)

NRG Oncology trial supports radiotherapy alone following radical hysterectomy should remain the standard of care for early-stage, intermediate-risk cervical cancer

Introducing our new cohort of AGA Future Leaders

Sharks are dying at alarming rates, mostly due to fishing. Retention bans may help

Engineering excellence: Engineers with ONR ties elected to renowned scientific academy

New CRISPR-based diagnostic test detects pathogens in blood without amplification

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

Growing solar: Optimizing agrivoltaic systems for crops and clean energy

Scientists discover how to reactivate cancer’s molecular “kill switch”

YouTube influencers: gaming’s best friend or worst enemy?

uOttawa scientists use light to unlock secret of atoms

NJIT mathematician to help map Earth's last frontier with Navy grant

NASA atmospheric wave-studying mission releases data from first 3,000 orbits

‘Microlightning’ in water droplets may have sparked life on Earth

Smoke from wildland-urban interface fires more deadly than remote wildfires

What’s your body really worth? New AI model reveals your true biological age from 5 drops of blood

Protein accidentally lassos itself, helping explain unusual refolding behavior

With bird flu in raw milk, many in U.S. still do not know risks of consuming it

University of Minnesota research team awarded $3.8 million grant to develop cell therapy to combat Alzheimer’s disease

UConn uncovers new clue on what is leading to neurodegenerative diseases like Alzheimer’s and ALS

Resuscitation in out-of-hospital cardiac arrest – it’s how quickly it is done, rather than who does it

A closer look at biomolecular ‘silly putty’

Oxytocin system of breastfeeding affected in mothers with postnatal depression

Liquid metal-enabled synergetic cooling and charging: a leap forward for electric vehicles

[Press-News.org] Mayo Clinic scientists propose a breast cancer drug for bladder cancer patients